2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of theVeterinary Biologics Market?
The escalation of animal diseases is anticipated to fuel the expansion of the veterinary biologics market. Animal diseases relate to ailments or health problems impacting various animal species. The rise in animal diseases amplifies the demand for improved diagnosis and treatment, which could be fulfilled with veterinary biologics, which utilize immunological techniques to address animal ailments. For instance, in October 2022, the European Center for Disease Prevention and Control, a health agency in Sweden representing the European Union, documented a total of 2,467 outbreaks of avian influenza in poultry, impacting 48 million birds, and 187 instances were identified in captive birds. Moreover, in July 2022, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that rabies annually results in 59,000 fatalities in more than 150 countries, with Africa and Asia accounting for 95% of cases. Consequently, the escalating incidences of animal diseases are propelling the growth of veterinary biologics.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp
#What is the Growth Potential of the Veterinary Biologics Market, and How Will It Perform by 2034?
In the last few years, the veterinary biologics market has experienced significant growth. It is set to expand from $12.67 billion in 2024 to $13.65 billion in 2025, displaying a compound annual growth rate (CAGR) of 7.7%. This growth during the historical period is mainly due to occurrences of animal diseases, regulatory backing and guidelines, the need for food safety, the globalisation of commerce and the economic importance of livestock.
The market size of veterinary biologics is anticipated to experience robust growth in the coming years, soaring to $18.38 billion by 2029 with a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth over the predicted period include the rise of emerging infectious diseases, shifts in climate and disease patterns, precision in livestock farming, the application of the one health approach, and the growing trend of pet ownership. Key trends observed during the forecast period encompass educational and training programmes, the use of eco-friendly and sustainable biologics, implementation of digital health records, an increase in biologics for companion animals, and personalized and targeted treatment methods.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12366
How Are Consumer Market Innovations Shaping the Current and Future Landscape of theVeterinary Biologics Market?
Leading businesses in the veterinary biologics market are putting their efforts into creating innovative biologics such as vaccines to improve animal health and prevent disease. A vaccine activates the immune system to identify and challenge particular pathogens, contributing to infectious disease prevention by nurturing immunity. For example, in August 2024, US-based global animal health firm, Merck Animal Health, introduced a research-based autogenous vaccine aimed at avian metapneumovirus (aMPV) type B. The vaccine received clearance from the U.S. Department of Agriculture (USDA) for production and distribution. It was created in partnership with Cambridge Technologies to tackle respiratory problems caused by aMPV type B in poultry, which have resulted in substantial financial losses since 2023. The vaccine is produced in a cutting-edge Minnesota facility and features an oil and water emulsion formulation to reduce tissue reactions post-vaccination. This addresses a crucial gap in the market since no commercially approved vaccines were previously accessible.
Who Are the Key Market Players Influencing the Growth of the Corn and Veterinary Biologics Industry?
Major companies operating in the veterinary biologics market include Bayer AG, Eli Lilly & Company, Evonik Industries AG, Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Vetoquinol, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report
Which Key Market Segments Comprise the Veterinary Biologics Market and Drive Its Revenue Growth?
The veterinary biologics market covered in this report is segmented –
1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products
2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases
3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels
4) By Application: Production Animal, Companion Animal
Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines
2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits
3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants
4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums
5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12366&type=smp
Which Regions Are Emerging as Leaders in the Veterinary Biologics Market?
North America was the largest region in the veterinary biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Veterinary Biologics Maret 2025, By The Business Research Company:
Veterinary Pharmaceuticals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report
Veterinary Anesthesia Equipment Global Market Report 2024
Veterinary Disposables Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-disposables-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
